CERVOMED INC (CRVO)
(Delayed Data from NSDQ)
$13.75 USD
+0.25 (1.85%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $13.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
CervoMed Inc. (CRVO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$49.60 | $65.00 | $30.00 | 267.41% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for CervoMed Inc. comes to $49.60. The forecasts range from a low of $30.00 to a high of $65.00. The average price target represents an increase of 267.41% from the last closing price of $13.50.
Analyst Price Targets (5 )
Broker Rating
CervoMed Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/18/2024 | Chardan Capital Markets | Daniil Gataulin | Not Available | Strong Buy |
7/25/2024 | Canaccord Genuity | Sumant Kulkarni | Strong Buy | Strong Buy |
7/8/2024 | Brookline Capital Markets | Tyler Bussian | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $49.60 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | -0.41 |
CRVO FAQs
CervoMed Inc. (CRVO) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for CervoMed Inc. (CRVO) is $49.60. The current on short-term price targets is based on 4 reports.
The forecasts for CervoMed Inc. (CRVO) range from a low of $30 to a high of $65. The average price target represents a increase of $260.73 from the last closing price of $13.75.
The current UPSIDE for CervoMed Inc. (CRVO) is 260.73%
Based on short-term price targets offered by five analysts, the average price target for CervoMed Inc. comes to $49.60. The forecasts range from a low of $30.00 to a high of $65.00. The average price target represents an increase of 267.41% from the last closing price of $13.50.